Skip to main content

COVID-19 Newsletter #4

Finding reliable information on the Covid-19 vaccine rollout can be challenging. Get this biweekly newsletter delivered to your email by signing up for our COVID-19 newsletter.

covid-vaccine

Vaccination Eligibility

Oregon and Washington continue to vaccinate eligible persons in phases 1A and 1B. Generally, these include health care workers, high-risk groups, and +65 years old. Washington is also vaccinating adults 50 years and older who live in multigenerational homes while Oregon is vaccinating childcare providers and k-12 educators and staff.

Please consult your state’s vaccination eligibility documents and take their questionnaires to determine if you currently qualify for the COVID-19 vaccine. If you qualify, your county health department will have information on where you can get your vaccine.

Washington Vaccine Rollout Plan // Washington Eligibility Questionnaire

Oregon Vaccine Rollout Plan // Oregon Eligibility Questionnaire and Vaccine Sign-Up


Johnson & Johnson Vaccine Information

The CDC has authorized the use of a new vaccine in the United States. The Johnson & Johnson COVID-19 vaccine (also known as the Janssen vaccine) requires only a single dose and boasts an 85% efficacy against sever infection. Common side effects are reported to be mild, but may include pain at the injection site, headache, fatigue, and muscle pain. This vaccine is also unique in that it only requires basic refrigeration, offering more flexibility in its transportation and storage options than previous vaccines. This vaccine should begin to show up in select vaccination sites across the country as early as March 2nd.


Updated Pfizer Vaccine Storage Requirements

The Food and Drug administration eased the deep cold storage requirements for the Pfizer vaccine last week. Now the vaccine can be moved and stored using more traditional freezer equipment, leading to wider eligibility among health care outlets for this type of vaccine.


COVID-19 Variants

The United States continues to monitor COVID-19 variants as they appear across the country. These variants highlight the need to continue social distancing, mask wearing, and good hygiene practices. While current vaccines are showing good efficacy in combating these new strains, we are simply nowhere close to the immunity numbers we’d need to see to begin relaxing our prevention measures. Slowing the spread of COVID-19 is our greatest defense against any current or future variants.

 

Thank you for visiting our COVID-19 News Blog. To get this information delivered to your inbox every 2 weeks, sign up for our newsletter here.